References
Original article
Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24–34 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. LAG3 inhibition improves outcomes. Nat Rev Clin Oncol 19, 149 (2022). https://doi.org/10.1038/s41571-022-00602-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00602-8
- Springer Nature Limited